Sign in

CIK 0000842023 · Large accelerated filer

BIO-TECHNE Corp

Sign in to watch
Ticker
TECH
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jun 30
Incorporated
MN
Entity type
operating
EIN
411427402
Phone
612-379-8854
Business address
614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
Former names
TECHNE CORP /MN/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-08-23 HIGGINS JOHN L Director Option exercise +10,000 $61.08 $611K 13,012
2018-08-23 HIGGINS JOHN L Director Sale −10,000 $187.92 $1.9M 3,012
2018-08-23 HIGGINS JOHN L Director Option exercise · Stock Option (right to buy) −10,000 0
2018-08-18 Kummeth Charles R. Chief Executive Officer Shares withheld for taxes −1,338 $180.50 $242K 92,176
2018-08-08 Kelderman Kim President, Diagnostics & Genom Grant or award · Restricted Stock Units +1,691 1,691
2018-08-08 Kelderman Kim President, Diagnostics & Genom Grant or award · Stock Options (Right to buy) +12,044 12,044
2018-08-08 Kelderman Kim President, Diagnostics & Genom Grant or award · Stock Options (Right to buy) +9,033 9,033
2018-08-08 Dinarello Charles A Director Option exercise +5,000 $63.03 $315K 13,212
2018-08-08 Dinarello Charles A Director Sale −5,000 $176.94 $885K 8,212
2018-08-08 Dinarello Charles A Director Option exercise · Stock Options (Right to buy) −5,000 0
2018-08-08 Kummeth Charles R. Chief Executive Officer Grant or award +11,279 93,514
2018-08-08 Kummeth Charles R. Chief Executive Officer Grant or award · Restricted Stock Units +16,918 16,918
2018-08-08 Kummeth Charles R. Chief Executive Officer Grant or award · Stock Options (Right to buy) +60,222 60,222
2018-08-08 Kummeth Charles R. Chief Executive Officer Grant or award · Stock Options (Right to buy) +90,334 90,334
2018-08-08 Eansor Norman David SVP - Novus Biologicals Grant or award · Restricted Stock Units +2,537 2,537
2018-08-08 Eansor Norman David SVP - Novus Biologicals Grant or award · Stock Options (Right to buy) +18,066 18,066
2018-08-08 Eansor Norman David SVP - Novus Biologicals Grant or award · Stock Options (Right to buy) +13,550 13,550
2018-08-08 Furlow Brenda S. SVP - General Counsel Grant or award · Restricted Stock Units +1,374 1,374
2018-08-08 Furlow Brenda S. SVP - General Counsel Grant or award · Stock Options (Right to buy) +9,786 9,786
2018-08-08 Furlow Brenda S. SVP - General Counsel Grant or award · Stock Options (Right to buy) +7,339 7,339

Page 54 of 64 · 1,274 trades